Compare Hims and Hers Health Inc (HIMS) vs Wells Fargo & Co (WFC) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

Wells Fargo (WFC) trades at $86.3, down 1.4% on the day, with a bullish technical outlook from moving averages and a consensus analyst price target of $97.36. The bank reported strong Q2 2026 earnings, beating EPS estimates with $1.96 actual versus $1.73 expected, driven by net interest income and fee growth. Revenue trends show steady growth from $83.7B in 2025 to a projected $87.0B in 2026, with net income margins improving to 25.97%. Recent news highlights AI investments in wealth management and a healthy investment banking pipeline.

The outlook for WFC is positive, supported by earnings momentum, dividend payments, and analyst upgrades. Key opportunities include continued revenue growth and efficiency gains post-asset cap removal. Risks involve net interest margin pressure, expense management challenges, and macroeconomic sensitivity. Institutional sentiment is mixed but leans bullish, with 45% of analysts rating it a buy.